Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03876054 · ClinicalTrials.gov registry record
Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
A clinical trial of Chronic Pain, sponsored by Abbott Medical Devices.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 20
- Study locations
NCT03876054: Recruiting study of Chronic Pain, sponsored by Abbott Medical Devices.
NCT03876054 is a study of Chronic Pain that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 2,000 participants, above the 766-participant average among 301 other Chronic Pain trials with a reported enrollment target (161% higher). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03876054, a study of Chronic Pain, is actively recruiting participants, sponsored by Abbott Medical Devices.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The REALITY study is a prospective, post-market, non-randomized, multi-center, single-arm, open-label study intended to collect short- and long-term safety and effectiveness data on various populations implanted with Abbott's neurostimulation systems.
Primary Outcome
Serious adverse device effects (SADEs), adverse device effects (ADEs), deaths, and device deficiencies will be summarized using counts, percentages or Kaplan-Meier survival estimates. This study has no primary or secondary endpoints, all endpoints are of equal weight.
Conditions Studied
Interventions
- DEVICE Spinal cord stimulation (SCS)
- DEVICE Dorsal root ganglion stimulation (DRG)
Study Locations (20)
California
- California Orthopedics & Spine - Larkspur
- Restore Orthopedics & Spine Center - Orange
- Foothills Pain Management Clinic - Pomona
- Pacific Research Institute - Santa Rosa
Minnesota
- Nura - Edina
- Twin Cities Pain Clinic - Edina
- Mayo Clinic - Rochester
New York
- Ainsworth Institute of Pain Management - New York
- Unity Spine Center - Rochester
- The Spine & Pain Institute of New York - Staten Island
Arizona
- Phoenician Centers for Research & Innovation - Phoenix
- Pain Institute of Southern Arizona - Tucson
Illinois
- Rush University Medical Center - Chicago
- University of Chicago - Chicago
Nevada
- Advanced Pain Care - Henderson
- Nevada Advanced Pain Specialists - Reno
Florida
- University of Florida Department of Anesthesia - Gainesville
Indiana
- Goodman Campbell Brain and Spine - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2019-03-13 |
| Est. Completion | 2029-12 |
What NCT03876054 shows while recruiting
NCT03876054 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 766-participant average among 301 other Chronic Pain trials with a reported enrollment target (161% higher).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Spinal cord stimulation (SCS) is the first listed.
NCT03876054 names 20 study sites across 10 states, led by California, Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT03876054 about?
NCT03876054 is a clinical study titled "Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator". The REALITY study is a prospective, post-market, non-randomized, multi-center, single-arm, open-label study intended to collect short- and long-term safety and effectiveness data on various populations implanted with Abbott's neurostimulation systems.
What is the current status of trial NCT03876054?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2019-03-13. Estimated completion is 2029-12.
What conditions does trial NCT03876054 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT03876054?
The interventions under investigation include: Spinal cord stimulation (SCS) (DEVICE), Dorsal root ganglion stimulation (DRG) (DEVICE).
Who is sponsoring clinical trial NCT03876054?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03876054 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03876054's enrollment target sits among peer trials
2,000 8th of 301 higher than 294 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI